Search by Drug Name or NDC

NDC 29300-0169-05 Tizanidine 4 mg/1 Details

Tizanidine 4 mg/1

Tizanidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Unichem Pharmaceuticals (USA), Inc.. The primary component is TIZANIDINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Tizanidine is used to relieve the spasms and increased muscle tone caused by multiple sclerosis (MS, a disease in which the nerves do not function properly and patients may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control), stroke, or brain or spinal injury. Tizanidine is in a class of medications called skeletal muscle relaxants. It works by slowing action in the brain and nervous system to allow the muscles to relax.

Related Packages: 29300-0169-05
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tizanidine

Product Information

NDC	29300-0169
Product ID	29300-169_1ff0cf9a-9b0b-4733-9ed7-315a09c60555
Associated GPIs	75100090100320
GCN Sequence Number	030274
GCN Sequence Number Description	tizanidine HCl TABLET 4 MG ORAL
HIC3	H6H
HIC3 Description	SKELETAL MUSCLE RELAXANTS
GCN	14693
HICL Sequence Number	011582
HICL Sequence Number Description	TIZANIDINE HCL
Brand/Generic	Generic
Proprietary Name	Tizanidine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tizanidine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	4
Active Ingredient Units	mg/1
Substance Name	TIZANIDINE HYDROCHLORIDE
Labeler Name	Unichem Pharmaceuticals (USA), Inc.
Pharmaceutical Class	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA091283
Listing Certified Through	2024-12-31

Package

NDC 29300-0169-05 (29300016905)

Pricing Information	N/A
NDC Package Code	29300-169-05
Billing NDC	29300016905
Package	500 TABLET in 1 BOTTLE, PLASTIC (29300-169-05)
Marketing Start Date	2013-04-01
NDC Exclude Flag	N